PUMA BIOTECHNOLOGY, INC.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Mar 2017 | — | $167.4M | $105.1M |
| Jun 2017 | — | $120.1M | $80.8M |
| Sep 2017 | — | $79.2M | $79.7M |
| Dec 2017 | $48.5M | $53.3M | $81.7M |
| Mar 2018 | $48.6M | $57.5M | $78.6M |
| Jun 2018 | $120.3M | $38.3M | $95.9M |
| Sep 2018 | $121.1M | $45.9M | $68.3M |
| Dec 2018 | $151.9M | $34.3M | $108.4M |
| Mar 2019 | $152.8M | $43.5M | $48.8M |
| Jun 2019 | $93.4M | $21.8M | $27.2M |
| Sep 2019 | $94.2M | $17.2M | $58.9M |
| Dec 2019 | $95.0M | $17.5M | $60.0M |
| Mar 2020 | $95.8M | $9.4M | $83.4M |
| Jun 2020 | $96.6M | $23.4M | $90.9M |
| Sep 2020 | $91.7M | $-453.0K | $90.1M |
| Dec 2020 | $84.0M | $-6.0M | $85.3M |
| Mar 2021 | $76.3M | $16.3M | $95.7M |
| Jun 2021 | $68.7M | $29.5M | $89.8M |
| Sep 2021 | $96.8M | $-10.9M | $63.9M |
| Dec 2021 | $97.1M | $-2.4M | $63.1M |
| Mar 2022 | $97.4M | $7.1M | $63.9M |
| Jun 2022 | $97.7M | $19.7M | $52.8M |
| Sep 2022 | $98.0M | $22.2M | $78.0M |
| Dec 2022 | $98.3M | $21.6M | $76.2M |
| Mar 2023 | $98.6M | $25.8M | $61.4M |
| Jun 2023 | $87.6M | $30.4M | $60.0M |
| Sep 2023 | $76.6M | $38.7M | $81.8M |
| Dec 2023 | $65.7M | $53.4M | $84.6M |
| Mar 2024 | $54.7M | $51.0M | $76.8M |
| Jun 2024 | $43.7M | $48.5M | $67.1M |
| Sep 2024 | $32.7M | $71.1M | $67.3M |
| Dec 2024 | $21.7M | $92.1M | $69.2M |
| Mar 2025 | $10.6M | $97.1M | $63.0M |
| Jun 2025 | $10.9M | $104.7M | $54.7M |
| Sep 2025 | $0 | $115.3M | $53.5M |
| Dec 2025 | $0 | $130.3M | $29.6M |
| Mar 2026 | $0 | $128.4M | $36.2M |
| Jun 2026 | $0 | $138.5M | $36.5M |